Literature DB >> 7927162

Medical innovation duels cost containment.

R A Rettig.   

Abstract

The nation's commitment to health cost control will potentially conflict with its deeper commitment to innovation in medical technology--drugs, medical devices, diagnostic and therapeutic procedures, and administrative infrastructure. Medical technology is implicated in increasing health care costs because, on a net basis, it increases the capabilities of medicine. Conceptual, methodological, institutional, and political factors limit the ability to address the potential conflict; these limits must be confronted and addressed if we are to formulate sound policy responses.

Mesh:

Year:  1994        PMID: 7927162     DOI: 10.1377/hlthaff.13.3.7

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  7 in total

Review 1.  The societal value of pharmaceuticals. Balancing industrial and healthcare policy.

Authors:  J Grund
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

2.  The emergence of clinical practice guidelines.

Authors:  George Weisz; Alberto Cambrosio; Peter Keating; Loes Knaapen; Thomas Schlich; Virginie J Tournay
Journal:  Milbank Q       Date:  2007-12       Impact factor: 4.911

Review 3.  Healthcare costs for new technologies.

Authors:  Mathias Goyen; Jörg F Debatin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

4.  Osler meets the marketplace--speculations on the future of internal medicine in the 21st century.

Authors:  M A Kelley
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

5.  Medical technology as a key driver of rising health expenditure: disentangling the relationship.

Authors:  Corinna Sorenson; Michael Drummond; Beena Bhuiyan Khan
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-30

6.  The quality of medical care, behavioral risk factors, and longevity growth.

Authors:  Frank R Lichtenberg
Journal:  Int J Health Care Finance Econ       Date:  2010-12-25

7.  Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs.

Authors:  Enrica Menditto; Valentina Orlando; Silvia Coretti; Daria Putignano; Denise Fiorentino; Matteo Ruggeri
Journal:  Clinicoecon Outcomes Res       Date:  2015-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.